Zoé van Kempen
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients (NCT04498286) | Zoé van Kempen | 2020-08-08 |
Track Zoé van Kempen automatically
Every clearance here is in the API, with alerts when new ones post.